Fasting and Caloric Restriction Activate an <scp>ADIOL</scp> ‐ <scp>NHR</scp> ‐91‐Kynurenine Pathway Signaling Axis to Promote Healthspan
The steroid hormone 5-androstene-3β,17β-diol (ADIOL) was discovered nearly a century ago in humans, yet its physiological functions have remained poorly understood. Using C. elegans, we identify ADIOL as essential for several pro-healthspan effects of fasting and caloric restriction (CR). These dietary restriction regimens activate an ADIOL-NHR-91-kynurenic acid signaling axis, partly through transcriptional programs associated with ADIOL biosynthesis. Within this axis, ADIOL acts through NHR-91, a C. elegans homolog of estrogen receptor β, to reduce levels of kynurenic acid, a neuromodulatory metabolite, thereby enhancing healthspan. Critically, ADIOL does not extend lifespan, indicating its healthspan benefits are independent of longevity, and even late-life supplementation is effective. Collectively, this work establishes ADIOL as a physiological link between metabolic cues and neural function, promoting health during aging via the kynurenine pathway. Given that in mammals ADIOL similarly is a ligand for estrogen receptor β and the kynurenine pathway influences neuroprotection mechanisms, ADIOL may represent an evolutionarily conserved signal by which dietary interventions enhance healthy aging.
Authors
- George A. Lemieux (ORCID: https://orcid.org/0000-0002-8519-8057)
- Shinja Yoo
- Kaveh Ashrafi (ORCID: https://orcid.org/0000-0002-5887-0346)
- Ana Guijarro-Hernández (ORCID: https://orcid.org/0000-0003-1061-7744)
- Rutuja Patil
- Sena Komatsu
- Abdullah Q. Latiff
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- Aging Cell
- Published
- 2026-04-22
- DOI
- https://doi.org/10.1111/acel.70496
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sandler Foundation
- National Institutes of Health
- University of California, San Francisco